Just want to clarify that the ontology should be generic enough to
handle different neurological diseases such as AD and PD. Also, it may
be possible to integrate the ontology (although it's not OWL-based) into
the current bioont effort.
Best,
-Kei
kc28 wrote:
Hi June, Don, et al,
As p
Hi June, Don, et al,
As part of the BioRDF's SenseLab task, we have recently created an RDFS
ontology for BrainPharm (a subdatabase of SenseLab). The ontology can be
used to model information about the effect of drugs on pathological (or
molecular) mechanisms (which involve neuronal propertie
Thanks Don. I think we'll hunker down with the article for a while,
and if any questions come up, perhaps she could answer them via
email. That may be the most efficient way to proceed at this point.
Cheers,
June
On Jan 31, 2007, at 2:48 PM, Donald Doherty wrote:
Hi All,
Susan Catalano
Hi All,
Susan Catalano said she'd be happy to join one of the HCLSIG teleconference
calls to answer questions about ADDL (if there is still a need).
Don
-
Donald Doherty, Ph.D.
Brainstage Research, Inc.
www.brainstage.com
[EMAIL PROTECTED]
412-683-1410
